WBR Insights - Supply Chain

Change is on the horizon! Mounting financial pressures and increased risk and uncertainty are forcing leaders to strip back to essentials, prioritising visibility and efficiency. The answer? Innovation. Download your FREE copy here 👉 https://lnkd.in/eBJakn8J Our LogiPharma Playbook dives deep into the cutting-edge solutions transforming pharma supply chains. Here are just a few key lessons from chapter one: 🌐 Planning & Resilience Take Center Stage: Over half of supply chain leaders are laser-focused on improving planning capabilities and building resilience in the face of rising geopolitical tensions. 🤖 Gene Therapy's Disruptive Potential: The high-risk, high-reward nature of gene therapies demands radically new supply chain models. Two-thirds of respondents believe this is essential. 🔥 Digital Networks: The Path to Success: By harnessing the power of digital networks, organisations can navigate turbulence with speed and confidence. AI: Redefining Pharma Supply Chains: A whopping 74% of leaders see AI's value in supply chain planning, closely linked to risk management. The takeaway? Embracing technology is the key to unlocking resilience and success in today's challenging landscape. #Supplychain #PharmaInsights #Insights

On Wednesdays, we talk about circular business models. Unlock the secrets to a greener future by checking out the full report by clicking here 👉 https://lnkd.in/gvZX3bCM Today we bring you one of the standout takeaways from the LogiChem Sustainability Through Collaboration Report. ♻️🚀Unleash the value of circular business models   Many in the industry are realising the value of circular business models. Beyond waste reduction, which will go some way to reducing overall emissions, implementing a circular business model can cut costs and reduce reliance on raw materials, as well as the associated price volatility. While implementation challenges remain, adopting a circular business model can ensure you stay ahead of the curve at such a critical time for the industry. #SupplyChain #SupplyChainInsights #Insights

✅ After interviewing 100 senior leaders in the European chemicals supply chain, we've identified key strategies for boosting sustainability through collaboration. Read on for one of the key takeaways from our research. Unlock the secrets to a greener future by checking out the full report by clicking here 👉 https://lnkd.in/gvZX3bCM 🚛✅Understand your transport providers   If we want to truly tackle Scope 3 emissions, having the buy-in and willingness from third parties such as transportation solution providers is critical. As one of our contributors to this report told us, understanding the position transportation providers are in, and working with them to ease concerns around areas such as emission data sharing can go a long way to enhancing the accuracy and consistency of their data reporting. #SupplyChain #SupplyChainInsights #Insights

The LogiPharma Playbook 2024 is here, highlighting a transformative shift in our industry: AI is set to revolutionise pharma by identifying patterns and trends, optimising planning capabilities, and so much more. 🌐✨ Download your FREE copy here 👉 https://lnkd.in/eBJakn8J Why does this matter?   AI's ability to sift through vast amounts of data offers unprecedented opportunities for cost-saving and efficiency. Imagine more precise demand forecasting, streamlined supply chains, and improved patient outcomes—all within our reach. The challenge? With great power comes great responsibility. The sheer volume of data necessary to harness AI's capabilities also heightens the risk of security breaches. As we move forward, we must address these vulnerabilities head-on. Key takeaway: To fully capitalise on AI's potential, we must prioritise robust security measures. This involves: 🔵 Implementing advanced cybersecurity protocols. 🔵 Regularly updating and patching systems. 🔵 Ensuring data encryption and access controls. By taking these proactive steps, supply chain leaders can safeguard our data while reaping the benefits AI offers, driving innovation and maintaining trust within our industry. 🔒💡 #Supplychain #PharmaInsights #Insights

Spice up your mid-week scrolling with a key finding from our LogiChem Sustainability Through Collaboration Report. Be part of the journey…. Download your FREE copy here 👇   https://lnkd.in/gvZX3bCM Circular business models   In their efforts to reduce waste and minimise carbon emissions, many are implementing circular business models. Once successfully integrated, circular business models will be key value creators, lowering the costs of materials through recycling and decreasing energy consumption. According to our research, 84% of organisations surveyed are either developing a circular business model, or plan to implement one in the next two to five years. 📊🌍 #SupplyChain #SupplyChainInsights #Insights

According to the LogiPharma Playbook, a staggering 57% of supply chain leaders are prioritising enhancing their capabilities to navigate today's turbulent conditions. Download your FREE copy here 👉 https://lnkd.in/eBJakn8J  Here's a snapshot of the key findings shaping the industry: 🔍 Expanding Internal Capabilities: With a surge in outsourcing and innovative modalities, organisations must bolster their internal capabilities to stay resilient. Collaboration is key, as highlighted by the 47% prioritising partnerships within the supply chain. 🌱 Sustainability at the Forefront: Sustainability isn't just a buzzword; it's a driving force behind transformative change. In fact, 43% of leaders seeing it as a top benefit for supporting corporate sustainability initiatives. 🌍 ESG Agenda: Despite uncertainties, leaders are committed to driving impactful change. From reducing emissions to leveraging automation technologies for increased productivity, the industry is rallying behind ESG pledges to shape a greener future. 💊 Patient-Centric Approach: Drug shortages and rising costs continue to pose challenges, impacting patient care. However, supply chain leaders recognise the importance of adaptability and are actively working to minimise disruptions and ensure access to vital medicines. 🔒 Data Security Concerns: As data becomes increasingly critical, cybersecurity remains a top priority with 31% of respondents citing data breaches and security as their biggest challenge. 🤖 AI Revolution: Artificial intelligence is reshaping supply chain dynamics, with leaders focusing on value addition and risk management. By harnessing automation, organisations aim to optimise operations and mitigate the escalating costs of research and drug development. The journey ahead may be fraught with challenges, but it's also ripe with opportunities for innovation and collaboration. #Supplychain #PharmaInsights #Insights

🚀 Exciting revelations from the LogiChem Sustainability Through Collaboration Report sheds light on key strategies shaping a greener future. Be part of the journey…. Download your FREE copy here 👇   https://lnkd.in/gvZX3bCM Here is a standout finding:   A Data Sharing Challenge   Chemical supply chain leaders face tough challenges around sharing data with key stakeholders in their efforts to reduce carbon emissions. Forty-six per cent of respondents said data silos remain their biggest challenge. With so many incompatible systems stretched across all functions, chemical manufacturers are struggling to access data in a standardised format which permits accurate and timely sharing. 🌐📈 The research in our report has built a collaborative sustainability road map for supply chain leaders to follow to push forward their sustainability goals!💡   #SupplyChain #SupplyChainInsights #Insights

Tired of reading ‘insightful reports’ but not knowing where those insights are coming from? Well, we’re not going to keep you in the dark 💡 here’s how we created our highly anticipated LogiPharma 2024 Playbook... Download your FREE copy here 👉 https://lnkd.in/eBJakn8J 📈 To capture the pulse of this thriving industry, WBR Insights surveyed 150 supply chain leaders in Q1 of 2024. Through in-depth telephone appointments 📞 WBR Insights engaged with supply chain leaders, unravelling the top challenges that organisations are currently face: 🌐 Diverse Perspectives from across Europe: The survey reflects the voices of leaders from various organisations' in Europe providing a comprehensive view of the challenges and opportunities shaping the pharma landscape. 📆 🍃 🔗 Innovative Solutions on Display: What sets this report apart is the exploration of innovative sustainable solutions. Pharma companies are not just identifying challenges; they are actively bringing groundbreaking solutions to the table. 🚀 🚛 🔗 Collaborative Insights: The results have been meticulously compiled and anonymised by WBR Insights, presenting a holistic view. Dive into the report to explore the analysis and commentary provided by industry experts from One Network Enterprises, Kinaxis, Tive Inc,  Shanghai Yuan Ting Technology Co , unconnected.org, and the vibrant LogiPharma community. 🤝 ♻️ The 2024 LogiPharma Playbook is not just a report; it's a roadmap for success. Join us in uncovering the trends, challenges, and innovations that will shape the future of the life science industry! 🌐 ✅ #Supplychain #PharmaInsights #Insights

🚀Every year, the urgency of achieving sustainability targets amplifies!   ✅To check out the full report, get your free download by clicking below. 👇   https://lnkd.in/gvZX3bCM ♻️🌳The conclusions we have drawn in the LogiChem Sustainability Through Collaboration Report are helping to draw a greener roadmap for how fostering a culture of collaboration can help the industry become more sustainable   📈🗣While progress has been made in enhancing the industry’s ESG data capabilities, challenges persist - notably surrounding data silos, privacy concerns and a lack of standardisation. To overcome these challenges, chemical manufacturers are realising that adopting a company-wide culture of open data sharing will be key to making meaningful progress in unlocking the power that data management enhancements can bring to the table when reducing carbon emissions.   🌐📈Equally, with waste reduction being a top priority for many, there has been a trend towards the implementation of circular business models. Circular business models allow chemical manufacturers to create value by cutting costs, reducing reliance on raw materials, and minimising energy consumption. However, this strategy is relatively new and those working on them face challenges in investment, having the necessary processes and technologies, and overcoming operational silos.   📊🌍Implementing a company-wide approach coupled with a collaborative culture with all stakeholders is paramount for successful decarbonisation progress. Collaborating with transportation solution providers, in particular, has been highlighted as a key focus, and heads of supply chain are facing challenges in these efforts, in part due to a lack of infrastructure for reporting data, increased costs and an unwillingness to share emission-based data from their transportation providers.   🗣🤝With regulations set to become more stringent and far-reaching, collaboration could be the key to evolving the chemicals industry towards carbon neutrality. Solutions are there, data is available and new technologies are emerging all of the time. Real progress hinges on coming together and sharing expertise and resources.   #SupplyChain #SupplyChainInsights #Insights

Despite the formidable challenges posed by drug shortages, the life sciences sector is pioneering innovative solutions to mitigate their impact. One standout strategy from the LogiPharma Playbook? Collaboration! Download your FREE copy here 👉 https://lnkd.in/eBJakn8J 🔑 Forming Resource Allocation Committees: By setting up dedicated committees that establish clear processes for approving alternative therapies and reassessing ethical considerations, organisations are better equipped to manage supply chain risks. This collaborative approach ensures that alternative solutions are swiftly vetted and implemented, minimising disruption to patient care. 🌟 Strengthening Resilience: These collaborative frameworks don’t just address immediate crises—they also enhance long-term resilience. By fostering partnerships across the industry, organisations can create a more robust and responsive supply chain, capable of adapting to future challenges. This includes: • Cross-Industry Partnerships: Engaging with stakeholders across the healthcare spectrum to share resources and knowledge. • Real-Time Data Sharing: Leveraging technology to enhance visibility and responsiveness across the supply chain. • Ethical Considerations: Ensuring that all alternative solutions are not only effective but also ethically sound, maintaining trust and compliance with regulatory standards. 👉 Addressing Drug Shortages is Crucial: In today’s rapidly evolving healthcare landscape, collaboration is the cornerstone of building a stronger, more adaptable supply chain. By working together, we can ensure that essential medicines are available when and where they are needed most. #Supplychain #PharmaInsights #Insights